BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31117294)

  • 21. Differentiation of gestational diabetes mellitus by nuclear magnetic resonance-based metabolic plasma analysis.
    Liu L; Liu L; Wang J; Zheng Q; Jin B; Sun L
    J Biomed Res; 2021 Jan; 35(5):351-360. PubMed ID: 34511531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome.
    Galazis N; Iacovou C; Haoula Z; Atiomo W
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):121-30. PubMed ID: 22136882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid levels in nascent metabolic syndrome: A contributor to the pro-inflammatory burden.
    Reddy P; Leong J; Jialal I
    J Diabetes Complications; 2018 May; 32(5):465-469. PubMed ID: 29559272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perturbation of serum metabolome in relation to type 2 diabetes mellitus and urinary levels of phthalate metabolites and bisphenols.
    Duan Y; Sun H; Yao Y; Han L; Chen L
    Environ Int; 2021 Oct; 155():106609. PubMed ID: 33965767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential serum biomarkers associated with HbA1c levels in Indian type 2 diabetic subjects using NMR-based metabolomics.
    Yousf S; Batra HS; Jha RM; Sardesai DM; Ananthamohan K; Chugh J; Sharma S
    Clin Chim Acta; 2024 Apr; 557():117857. PubMed ID: 38484908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria.
    Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R
    Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time Series Characteristics of Serum Branched-Chain Amino Acids for Early Diagnosis of Chronic Heart Failure.
    Li R; He H; Fang S; Hua Y; Yang X; Yuan Y; Liang S; Liu P; Tian Y; Xu F; Zhang Z; Huang Y
    J Proteome Res; 2019 May; 18(5):2121-2128. PubMed ID: 30895791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics-Based Prospective Studies and Prediction of Type 2 Diabetes Mellitus Risks.
    Satheesh G; Ramachandran S; Jaleel A
    Metab Syndr Relat Disord; 2020 Feb; 18(1):1-9. PubMed ID: 31634052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic characterization of diabetic retinopathy: An
    Jin H; Zhu B; Liu X; Jin J; Zou H
    J Pharm Biomed Anal; 2019 Sep; 174():414-421. PubMed ID: 31212142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach.
    Liu X; Gao J; Chen J; Wang Z; Shi Q; Man H; Guo S; Wang Y; Li Z; Wang W
    Sci Rep; 2016 Jul; 6():30785. PubMed ID: 27470195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies.
    Sriboonvorakul N; Pan-Ngum W; Poovorawan K; Muangnoicharoen S; Quinn LM; Tan BK
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomics reveals energetic impairments in Daphnia magna exposed to diazinon, malathion and bisphenol-A.
    Nagato EG; Simpson AJ; Simpson MJ
    Aquat Toxicol; 2016 Jan; 170():175-186. PubMed ID: 26655661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum metabolite signatures of type 2 diabetes mellitus complications.
    Wu T; Xie G; Ni Y; Liu T; Yang M; Wei H; Jia W; Ji G
    J Proteome Res; 2015 Jan; 14(1):447-56. PubMed ID: 25245142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear magnetic resonance-based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis.
    Gu J; Huang C; Hu X; Xia J; Shao W; Lin D
    Cancer Sci; 2020 Sep; 111(9):3195-3209. PubMed ID: 32369664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Fingerprint of Turner Syndrome.
    Bugajska J; Berska J; Wójcik M; Starzyk JB; Sztefko K
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32131408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model.
    Niu QY; Li ZY; Du GH; Qin XM
    J Pharm Biomed Anal; 2016 Jan; 118():338-348. PubMed ID: 26595282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative metabolic profiling of NMR spectral signatures of branched chain amino acids in blood serum.
    Ghosh S; Sengupta A; Chandra K
    Amino Acids; 2015 Oct; 47(10):2229-36. PubMed ID: 25991390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomics in human type 2 diabetes research.
    Lu J; Xie G; Jia W; Jia W
    Front Med; 2013 Mar; 7(1):4-13. PubMed ID: 23377891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.